Literature DB >> 22404874

The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes.

Tiziana Magnani1, Riccardo Valdagni, Roberto Salvioni, Sergio Villa, Lara Bellardita, Simona Donegani, Nicola Nicolai, Giuseppe Procopio, Nice Bedini, Tiziana Rancati, Nadia Zaffaroni.   

Abstract

UNLABELLED: Study Type - Therapy (decision analysis) Level of Evidence 2b. What's known on the subject? and What does the study add? The benefits of the multidisciplinary approach in oncology are widely recognised. In particular, managing patients with prostate cancer within a multidisciplinarity and multiprofessional context is of paramount importance, to address the complexity of a disease where patients may be offered multiple therapeutic and observational options handled by different specialists and having severe therapy-induced side-effects. The present study describes the establishing of a multidisciplinary clinic at the Prostate Cancer Programme of Milan Istituto Nazionale dei Tumori, its effects on the quality of care provided, and strategies implemented to meet upcoming needs and improve quality standards. Having analysed the data of the 2260 multidisciplinary clinics held from March 2005 to March 2011, our dynamic and modifiable organisational model was evaluated for ways to optimise the human resources, offer high-quality standards, meet new needs and ultimately reduce costs. The study is focused on the organisational aspects and adds a perspective from one of the major oncological centres of reference in Italy and in Europe.
OBJECTIVES: To describe the establishing of a multidisciplinary clinic for men with prostate cancer at the Istituto Nazionale Tumori, Milan. • To evaluate the quality of care provided and to describe the management changes implemented to improve standards and meet new needs.
MATERIALS AND METHODS: In March 2005, we established a multidisciplinary clinic comprising weekly clinics and case-discussion sessions. • We have altered the organisational model periodically to meet new needs and improve quality.
RESULTS: We held 2260 multidisciplinary clinics up to March 2011. • For stage distribution, patients with low-risk prostate cancer increased to a peak of 61% in 2009, probably because of the anticipation of diagnosis and the active surveillance expertise of the Prostate Cancer Programme at Istituto Nazionale Tumori, Milan. The slight decrease in 2010 might be due to the availability of robot-assisted prostatectomy in several hospitals in Milan, and the start of a multicentre active surveillance protocol in December 2009. • In terms of the efficacy of our multidisciplinary strategy, 11% of drug therapies (mostly hormones) prescribed outside our institute were terminated in the multidisciplinary clinic, and 6% of indications formulated in the multidisciplinary clinics were altered during the case-discussion sessions.
CONCLUSIONS: The multidisciplinary approach needs to be adaptable to meet new needs and improve quality. • Our experience has proved successful for both physicians and patients. The team agrees on strategies; complex cases are managed by a multidisciplinary team; dedicated psychologists contribute their knowledge and perspectives; and patients report the feeling of being cared for.
© 2012 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2012        PMID: 22404874     DOI: 10.1111/j.1464-410X.2012.10970.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  11 in total

1.  Quality assessment in prostate cancer centers certified by the German Cancer Society.

Authors:  Christoph Kowalski; Julia Ferencz; Peter Albers; Jan Fichtner; Thomas Wiegel; Günter Feick; Simone Wesselmann
Journal:  World J Urol       Date:  2015-09-21       Impact factor: 4.226

2.  Toward a common therapeutic framework in castration-resistant prostate cancer: a model for urologic oncology and medical oncology interaction.

Authors:  Ralph de Vere White; Primo N Lara
Journal:  Urol Oncol       Date:  2014-05       Impact factor: 3.498

Review 3.  Multidisciplinary management of Prostate Cancer: how and why.

Authors:  Alessandro Sciarra; Vincenzo Gentile; Valeria Panebianco
Journal:  Am J Clin Exp Urol       Date:  2013-12-25

4.  Impact of a single-day multidisciplinary clinic on the management of patients with liver tumours.

Authors:  J Zhang; M N Mavros; D Cosgrove; K Hirose; J M Herman; S Smallwood-Massey; I Kamel; A Gurakar; R Anders; A Cameron; J F H Geschwind; T M Pawlik
Journal:  Curr Oncol       Date:  2013-04       Impact factor: 3.677

5.  Prostate cancer: the benefits of multidisciplinary prostate cancer care.

Authors:  Leonard G Gomella
Journal:  Nat Rev Urol       Date:  2012-05-08       Impact factor: 14.432

6.  Establishment of a new prostate cancer multidisciplinary clinic: Format and initial experience.

Authors:  Debasish Sundi; Jason E Cohen; Alexander P Cole; Brian P Neuman; John Cooper; Farzana A Faisal; Ashley E Ross; Edward M Schaeffer
Journal:  Prostate       Date:  2014-10-13       Impact factor: 4.104

7.  Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic.

Authors:  Anna Patrikidou; Pierre Maroun; Jean-Jacques Patard; Hervé Baumert; Laurence Albiges; Christophe Massard; Yohann Loriot; Bernard Escudier; Mario Di Palma; Julia Arfi-Rouche; Laurence Rocher; Zahira Merabet; Alberto Bossi; Karim Fizazi; Pierre Blanchard
Journal:  Clin Transl Radiat Oncol       Date:  2018-07-06

8.  Supporting Patients With Untreated Prostate Cancer on Active Surveillance: What Causes an Increase in Anxiety During the First 10 Months?

Authors:  Maria Francesca Alvisi; Paola Dordoni; Tiziana Rancati; Barbara Avuzzi; Nicola Nicolai; Fabio Badenchini; Letizia De Luca; Tiziana Magnani; Cristina Marenghi; Julia Menichetti; Villa Silvia; Zollo Fabiana; Salvioni Roberto; Valdagni Riccardo; Bellardita Lara
Journal:  Front Psychol       Date:  2020-11-19

9.  Are multidisciplinary teams in secondary care cost-effective? A systematic review of the literature.

Authors:  K Melissa Ke; Jane M Blazeby; Sean Strong; Fran E Carroll; Andy R Ness; William Hollingworth
Journal:  Cost Eff Resour Alloc       Date:  2013-04-04

10.  'Act on oncology' as a new comprehensive approach to assess prostate cancer centres--method description and results of a pilot study.

Authors:  Wieland Voigt; Josef Hoellthaler; Tiziana Magnani; Vito Corrao; Riccardo Valdagni
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.